“Special Scrutiny”: A Targeted Form of Research Protocol Review
- 3 February 2004
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 140 (3) , 220-223
- https://doi.org/10.7326/0003-4819-140-3-200402030-00013
Abstract
Research participants require ongoing protection of the kind already established in law and regulation. However, “special scrutiny” for certain types of research is also needed. Three criteria for special scrutiny are 1) research that involves initial experiences of translating new scientific advances into humans, especially when the intervention is novel, irreversible, or both; 2) research with a known or credible risk for significant harm [death or serious disability are the clearest examples] to research participants as a consequence of the experimental intervention and with no potential for offsetting direct medical benefit; or 3) research with a protocol that raises ethical questions about research design or implementation for which there is no consensus. Special scrutiny recognizes that not all research protocols are equally ethically challenging and aims to provide appropriate protection for all research participants.Keywords
This publication has 29 references indexed in Scilit:
- The AbioCor implantable replacement heartThe Annals of Thoracic Surgery, 2003
- Position Paper of the Ethics Committee of the International Xenotransplantation AssociationXenotransplantation, 2003
- Total artificial heart: Destination therapyCardiology Clinics, 2003
- Xenotransplantation: Public Health Risks¡ªPatient vs. Society in an Emerging FieldPublished by Springer Nature ,2003
- Placebos that harm: sham surgery controls in clinical trialsStatistical Methods in Medical Research, 2002
- The hexamethonium asthma study and the death of a normal volunteer in researchJournal of Medical Ethics, 2002
- I Need a Placebo like I Need a Hole in the HeadJournal of Law, Medicine & Ethics, 2002
- The death of a healthy volunteer in a human research project: implications for Australian clinical researchThe Medical Journal of Australia, 1998
- Unethical Trials of Interventions to Reduce Perinatal Transmission of the Human Immunodeficiency Virus in Developing CountriesNew England Journal of Medicine, 1997
- The effect of inhaled hexamethonium bromide and atropine sulphate on airway responsiveness to histamineJournal of Allergy and Clinical Immunology, 1985